Showing results (191-200 of 242) with videos related to
Sort By:
Pageof 25
Genomics|September 15, 1996
Isolation of the ATP-binding human homolog of the arsA component of the bacterial arsenite transporterB Kurdi-Haidar, S Aebi, D Heath, et al.Cancer Research|September 1, 1996
Determinants of tamoxifen sensitivity control the nature of the synergistic interaction between tamoxifen and cisplatinE F McClay, J A Jones, P J Winski, et al.Molecular and Cellular Biology|September 11, 1992
Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell linesW Zhen, C J Link, P M O'Connor, et al.Journal of the National Cancer Institute|May 1, 1981
Cytotoxic activity, tumor accumulation, and tissue distribution of ruthenium-103-labeled bleomycinP H Stern, S E Helpern, P L Hagan, et al.International Journal for Parasitology|February 20, 2007
A novel approach for combining the use of in vitro and in vivo data to measure and detect emerging moxidectin resistance in gastrointestinal nematodes of goatsR M Kaplan, A N Vidyashankar, S B Howell, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1987
Long-term survival of advanced refractory ovarian carcinoma patients with small-volume disease treated with intraperitoneal chemotherapyS B Howell, S Zimm, M Markman, et al.Journal of the National Cancer Institute|May 1, 1991
Phase I and pharmacokinetic trial of intraperitoneal etoposide in combination with the multidrug-resistance-modulating agent dipyridamoleS Isonishi, S Kirmani, S Kim, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
Analysis of MLH1 and MSH2 expression in ovarian cancer before and after platinum drug-based chemotherapyG Samimi, D Fink, N M Varki, et al.Cancer Research|November 1, 1996
The role of DNA mismatch repair in platinum drug resistanceD Fink, S Nebel, S Aebi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Extended CSF cytarabine exposure following intrathecal administration of DTC 101S Kim, E Chatelut, J C Kim, et al.Pageof 25